Alpha memo: resveratrol exercise training translation boundary

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Remove or explicitly flag the ~4.1 mmHg MAP figure mentioned in the caveats, since it does not appear in the supplied Receipt 2 excerpt and cannot be verified; describe the blunting effect using only the title-level 'blunts' framing until a full-text source confirms the numeric value.
2. Tighten the 'Why this is surprising' section so that the Nrf2/FTH1/GPX4 mechanism is clearly labeled as derived from the Receipt 1 title (since the excerpt is truncated) rather than presented as confirmed from the abstract body.
3. Add a one-line explicit statement that Receipt 1 (mechanistic mouse) and Receipt 2 (small human RCT) are not directly comparable and that the 'translation boundary' is a cross-species inference, not a within-study contrast.
4. Consider expanding the gaps section with a concrete proposal for a pre-specified human replication (e.g., aged men, standardized resveratrol dose, primary cardiovascular endpoint with full MAP reporting) — the current text gestures at this but could be more actionable.

Minor issues

• The alpha sentence itself is proportionate and hedged ('may produce context-dependent signals'), but the caveats section raises the possibility of citing a ~4.1 mmHg MAP figure that is not actually present in the memo text — this is a self-contradiction that should be cleaned up by removing the unverifiable figure reference entirely.
• Receipt 1 excerpt is cut off mid-sentence ('tumor necrosis factor'), so the mechanistic Nrf2/FTH1/GPX4 framing relies partially on the title; this is acceptable given reference-only bundle norms but should be acknowledged as title-derived rather than excerpt-confirmed.
• The memo could briefly note that Receipt 1 is a mechanistic mouse study while Receipt 2 is a small human RCT, so the 'translation boundary' framing is explicitly about cross-species extrapolation rather than direct comparison.

Reviewer note

This is a competent alpha memo that correctly identifies a genuine translational tension: a 2023 mouse study showing resveratrol protects the intestine from high-intensity exercise damage via an Nrf2/FTH1/GPX4 axis, versus a 2013 human RCT (Gliemann et al.) in aged men where 250 mg/day resveratrol blunted training-induced cardiovascular gains. The memo is honest about heterogeneity across species, dose, duration, and endpoint family, and it explicitly flags the ~4.1 mmHg MAP figure as unverifiable from the supplied excerpt — that kind of self-auditing is exactly what an alpha memo should do. The synthesis is coherent: it makes one bounded signal clear (context-dependent, possibly split effects of resveratrol + exercise across tissue/system boundaries), it stays proportionate to the two receipts, and the limitations are material rather than generic. The source bundle correctly grounds both citations with matching titles, DOIs, years, and species/dose/duration details. Two minor issues prevent an accept: (1) the caveats mention an unverifiable ~4.1 mmHg figure that does not appear elsewhere in the memo, creating a minor internal inconsistency; (2) the cross-species framing could be more explicit. These are bounded edits, not structural problems — revise is appropriate rather than reject. The memo does not overclaim, does not assert clinical or policy recommendations, and appropriately hedges the 'translation boundary' framing as tentative.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis